SetAside Type | ||
Solicitation ID | Solicitation Title | Solicitation Office |
SPE2E2-24-R-0015 | Telmisartan Tablets | |
Synopsis | ||
Amendment 0004 has been made to accomdate for solicitation changes pursuant to the authority of CD 2025-O0003 and CD 2025-O0004. .... Read More |
||
Office Location | Agency Name | Solicitation Base Posting Type |
DEFENSE LOGISTICS AGENCY | Combined Synopsis/Solicitation |
SetAside Type | ||
Solicitation ID | Solicitation Title | Solicitation Office |
SPE2E2-24-R-0015 | Telmisartan Tablets | |
Synopsis | ||
Amendment 0003 has been issued to allow for e-mail submission on this solicitaiton. .... Read More |
||
Office Location | Agency Name | Solicitation Base Posting Type |
DEFENSE LOGISTICS AGENCY | Combined Synopsis/Solicitation |
SetAside Type | ||
Solicitation ID | Solicitation Title | Solicitation Office |
SPE2E2-24-R-0015 | Telmisartan Tablets | |
Synopsis | ||
Amendment 0002 has been issued to extend the solicitation closing date to February 28, 2025 3:00 PM EST. .... Read More |
||
Office Location | Agency Name | Solicitation Base Posting Type |
DEFENSE LOGISTICS AGENCY | Combined Synopsis/Solicitation |
SetAside Type | ||
Solicitation ID | Solicitation Title | Solicitation Office |
SPE2E2-24-R-0015 | Telmisartan Tablets | |
Synopsis | ||
Amendment 0001 has been issued to extend the solicitation closing date to February 21, 2025 3:00 PM EST. .... Read More |
||
Office Location | Agency Name | Solicitation Base Posting Type |
DEFENSE LOGISTICS AGENCY | Combined Synopsis/Solicitation |
SetAside Type | ||
Solicitation ID | Solicitation Title | Solicitation Office |
SPE2E2-24-R-0015 | Telmisartan Tablets | |
Synopsis | ||
Solicitation Attached. .... Read More |
||
Office Location | Agency Name | Solicitation Base Posting Type |
DEFENSE LOGISTICS AGENCY | Combined Synopsis/Solicitation |